Abstract
PurposeThe purpose of the present work is to improve the industry performance by identifying and quantifying the risks faced by the Indian pharmaceutical industry (IPI). The risk values for the prominent risks and overall industry are determined based on the four risk parameters, which would help determine the most contributive risks for mitigation.Design/methodology/approachAn extensive literature survey was done to identify the risks, which were also validated by industry experts. The finalized risks were then evaluated using the fuzzy synthetic evaluation (FSE) method, which is the most suitable approach for the risk assessment with parameters having a set of different risk levels.FindingsThe three most contributive sub-risks are counterfeit drugs, demand fluctuations and loss of customers due to partners' poor service performance, while the main risks obtained are demand, financial and logistics. Also, the overall risk value indicates that the industry faces medium to high risk.Practical implicationsThe study identifies the critical risks which need to be mitigated for an efficient industry. The industry is most vulnerable to the demand risk category. Therefore, the managers should minimize this risk by mitigating its sub-risks, like demand fluctuations, bullwhip effect, etc. Another critical sub-risk, the counterfeit risk, should be managed by adopting advanced technologies like blockchain, artificial intelligence, etc.Originality/valueThere is insufficient literature focusing on risk quantification. Therefore, this work addresses this gap and obtains the industry's most critical risks. It also discusses suitable mitigation strategies for better industry performance.
Subject
Strategy and Management,General Business, Management and Accounting
Reference141 articles.
1. To build or not to build, that is the uncertainty: fuzzy synthetic evaluation of risks for sustainable housing in developing economies;Cities,2022
2. A fuzzy synthetic evaluation of the challenges of smart city development in developing countries;Smart and Sustainable Built Environment,2020
3. Drug governance: IoT-based blockchain implementation in the pharmaceutical supply chain,2020
4. A conceptual framework for operational performance measurement in wholesale organisations;International Journal of Productivity and Performance Management,2022
5. Medications registration and marketing: safety-related issues;Drug Safety in Developing Countries,2020
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献